Article Cited by others


Ticagrelor: An emerging oral antiplatelet agent

Juneja Shivani, Gupta Kanchan, Kaushal Sandeep

Year : 2013| Volume: 4| Issue : 1 | Page no: 78-80

   This article has been cited by
1 Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention
Bangming Cao, Fuzheng Qu, Xianliang Liu, Changzheng Gao, Qiang Fu, Chunying Jiang, Peng Wei, Qianqian Ma
Aging. 2019; 11(20): 8925
[Pubmed]  [Google Scholar] [DOI]
2 Platelet activation and antiplatelet therapy in sepsis: A narrative review
Yuhui Wang,Yaqi Ouyang,Baoyan Liu,Xiaochun Ma,Renyu Ding
Thrombosis Research. 2018; 166: 28
[Pubmed]  [Google Scholar] [DOI]
3 Spontaneous hematoma in the setting of dual anti-platelet therapy with ticagrelor: A case report
Oncology Letters. 2016; 12(1): 144
[Pubmed]  [Google Scholar] [DOI]
4 A Case of Pulmonary Hemorrhage Due to Drug-Induced Pneumonitis Secondary to Ticagrelor Therapy
Timothy J. Whitmore,John P. OæShea,Diana Starac,Mark G. Edwards,Grant W. Waterer
Chest. 2014; 145(3): 639
[Pubmed]  [Google Scholar] [DOI]
5 Document A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy
Whitmore, T.J., OæShea, J.P., Starac, D., Edwards, M.G., Waterer, G.W.
Chest. 2014; 145(3): 639-641
[Pubmed]  [Google Scholar]


Read this article